Alzheimer's Disease Neuroimaging Initiative (ADNI-3)

Would you like to help us improve our understanding of how Alzheimer's disease develops and progresses in the brain? Are you between age 55 and 90, and have few or no memory concerns, a diagnosis of Mild Cognitive Impairment (MCI) or mild dementia due to Alzheimer's disease (AD)? You could be a part of medical history; please consider participating in the ADNI-3 study.

The purpose of the ADNI-3 study is to create a national database of brain aging to improve clinical trials and provide researchers across the country with data to study how quickly brain cognition and function changes. This study is funded by the National Institutes for Health.

  • This international study will enroll approximately 1,298 volunteers
  • This study will last for approximately 5 years
  • This study will involve office visits consisting of blood draws, memory and thinking tests, MRI scans and PET scans, and lumbar punctures (spinal tap)
  • Most of the visits for this trial will be conducted at the Center for Alzheimer Research and Treatment (CART) at Brigham & Women's Hospital, but a few visits will be conducted at Massachusetts General Hospital
  • There is no cost associated with participating in this study

If you are interested and would like more information, please contact:

Steve Smith: (t) (857) 307-5284, (e) ssmith31@bwh.harvard.edu

or

The Center for Alzheimer Resaerch and Treatment main line: (617) 732-8085

Download Flyer: